What Beta Bionics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 13 | 46 |
| Total trades | 13 | 61 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 155,772 |
| Disposed | 120,879 | 215,241 |
| Net activity | −120,879 | −59,469 |
Common stock only — 1 reported trade in the last 12 months is in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Hopman Mark | Chief Commercial Officer | Oct 14 | Open-market sale · S | −775 | $17.35 | −$13.4K | 55,334 |
| Hopman Mark | Chief Commercial Officer | Oct 01 | Open-market sale · S | −370 | $18.96 | −$7.02K | 56,109 |
| Jones Christy | Director | Sep 22 | Open-market sale · S | −6,430 | $23.00 | −$148K | 19,564 |
| Mensinger Mike | Chief Product Officer | Sep 16 | Open-market sale · S | −2,650 | $22.00 | −$58.3K | 177,390 |
| Hopman Mark | Chief Commercial Officer | Sep 16 | Open-market sale · S | −30,779 | $20.13 | −$620K | 56,479 |
| Hopman Mark | Chief Commercial Officer | Sep 14 | Open-market sale · S | −775 | $15.52 | −$12K | 86,382 |
| Hopman Mark | Chief Commercial Officer | Sep 09 | Disclosed 10b5-1 sale · S | −35,994 | $18.46 | −$665K | 88,033 |
| Saint Sean | President & CEO | Sep 03 | Open-market sale · S | −5,641 | $20.08 | −$113K | 398,429 |
| Saint Sean | President & CEO | Sep 02 | Open-market sale · S | −16,867 | $19.11 | −$322K | 404,070 |
| Feider Stephen | Chief Financial Officer | Sep 02 | Open-market sale · S | −6,675 | $19.11 | −$128K | 159,378 |
| Mensinger Mike | Chief Product Officer | Sep 02 | Open-market sale · S | −4,375 | $19.11 | −$83.6K | 180,040 |
| Russell Steven Jon | Chief Medical Officer | Sep 02 | Open-market sale · S | −4,221 | $19.11 | −$80.7K | 169,628 |
| Hopman Mark | Chief Commercial Officer | Sep 02 | Open-market sale · S | −5,327 | $19.11 | −$102K | 124,027 |
| Feider Stephen | Chief Financial Officer | Jun 29 | Open-market sale · S | −4,896 | $17.03 | −$83.4K | 166,053 |
| Feider Stephen | Chief Financial Officer | Jun 29 | Exercise / conversion · M | +4,896 | $5.10 | +$25K | 170,949 |
| Feider Stephen | Chief Financial Officer | Jun 26 | Open-market sale · S | −5,104 | $17.05 | −$87K | 166,053 |
| Feider Stephen | Chief Financial Officer | Jun 26 | Exercise / conversion · M | +5,104 | $5.10 | +$26K | 171,157 |
| Jones Christy | Director | Jun 24 | Open-market sale · S | −1,406 | $15.00 | −$21.1K | 25,994 |
| Hopman Mark | Chief Commercial Officer | Jun 24 | Open-market sale · S | −1,258 | $15.01 | −$18.9K | 129,354 |
| Jones Christy | Director | Jun 04 | Open-market sale · S | −2,811 | $14.00 | −$39.4K | 27,400 |
Loading...
